Howard Cox, DPM
Podiatrist · Mobile, ALNPI 1831267863
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Organogenesis Inc. at 49.4% of the total. 2025 is the largest year on record at $521, more than ten times the $28 reported in 2020. That places this record below the midpoint for podiatrist clinicians in AL, where the typical reported total is $1,120.
Across 46 payments — averaging $25.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$575
- Paratek Pharmaceuticals, Inc.$214
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$94
- Johnson & Johnson$76
- Globus Medical$53
- Nevro Corp.$43
- plus $109 from 5 others
What the payments were for
- Food & beverage$1,163100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 15 | $575 |
| Paratek Pharmaceuticals, Inc. | 12 | $214 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $94 |
| Johnson & Johnson | 4 | $76 |
| Globus Medical | 2 | $53 |
| Nevro Corp. | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| GRT US Holding, Inc. | 1 | $28 |
| AstraZeneca | 1 | $21 |
| Shield Therapeutics Inc | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $15 |
How this compares
$1,163 in reported general payments places this provider in the 50th percentile of 59 podiatrist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 183 | $4,010 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 124 | $2,627 |
| Gabapentin | 156 | $1,646 |
| Fluconazole | 47 | $1,072 |
| Doxycycline Monohydrate | 47 | $688 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $532 |
| Colchicine | 13 | $429 |
| Meloxicam | 29 | $232 |
| Duloxetine Hcl | 18 | $189 |
| Tramadol Hcl | 23 | $75 |
| Allopurinol | 11 | $39 |
| Prednisone | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Mobile
- James MorganMobile$21K
- Michael KayeMobile$3K
- David BorcickyMobile$2K
- George JohnsonMobile$1K
- Stuart AlterMobile$652
- Michael HamesFlorence$100K
- John RobersonBirmingham$10K
- Kyle MaukBirmingham$10K
- Johnnie AlstonMontgomery$9K
- Heidi ChristieMontgomery$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.